Oral cancer is 90% curable when found in its early stages. Unfortunately, 70% of oral cancers are diagnosed in the late stages, III and IV, because they are not visible to the human eye.

Oral cancer found in these late stages can lead to a five-year survival rate of 57%. Dr. Parsi uses ViziLite Plus, a technology that has proven successful in identifying soft tissue abnormalities in other areas of the body.

A ViziLite Plus exam is particularly important if you are at increased risk for developing oral cancer. How ViziLite Plus Works As ViziLite Plus passes over oral tissue that has been treated with the rinse solution, normal healthy tissue will absorb the light and appear dark, abnormal tissue will appear white. The purpose of using ViziLite Plus is to identify tissue changes at their earliest stage; once abnormal tissue has been identified it is up to your dental professional to determine what the appropriate next steps are.